Going green: what pharmas promise on the environment

Against the backdrop of imminent SEC rules that could require climate disclosures for all publicly traded companies, pharma ESG reports provide a snapshot of what environmental priorities and goals can look like. How smaller companies could adapt these goals to their own scale and priorities remains to be seen.

While environmental reporting rules would require many pre-revenue biotechs to build compliance capacity from scratch, voluntary climate disclosures have been a regular part of big pharma’s reporting for years. ...